IM

imbiologics Venture Capital

4 known investors

imbiologics.com ↗

IM Biologics develops innovative antibody-based therapeutics for autoimmune diseases and immuno-oncology using proprietary antibody modality optimization technology (IM-OpDECon). The company aims to address unmet medical needs by leveraging multiple antibody modalities to create differentiated treatments.

Investors · 4

AJ

Aju IB Invesment CorporationSeoul

AT

Atinum Investment Co. Ltd.Seoul · $100K – $2M

IM

IMM Investment JapanSeoul

SO

Solidus InvestmentSeoul